(Q40291320)

19 September 2017

title

Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais (English)

1 reference

19 September 2017

1 reference

Chingching Foocharoen

1

1 reference

19 September 2017

Piyakarn Watcharenwong

2

1 reference

19 September 2017

Sittichai Netwijitpan

3

1 reference

19 September 2017

Ajanee Mahakkanukrauh

4

1 reference

19 September 2017

Siraphop Suwannaroj

5

1 reference

19 September 2017

Ratanavadee Nanagara

6

1 reference

19 September 2017

language of work or name

1 reference

10 March 2017

1 reference

International Journal of Rheumatic Diseases

19 September 2017

published in

1 reference

Clinical aspects of systemic sclerosis (scleroderma)

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical and serological features of systemic sclerosis in a Chinese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Autoantibodies in systemic sclerosis: unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Overlap connective tissue disease syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

An epidemiological study of scleroderma in the West Midlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Pathogenic autoantibodies in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical and laboratory aspects of Ro/SSA-52 autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.13060

21 January 2018

Identifiers

DOI

10.1111/1756-185X.13060

1 reference

19 September 2017

1 reference